Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

ClinicalTrials.gov ID: NCT00111618

Public ClinicalTrials.gov record NCT00111618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 9:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Study identification

NCT ID
NCT00111618
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Antisoma Research
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

  • AS1404 (DMXAA) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2005
Primary completion
May 31, 2007
Completion
Jul 31, 2008
Last update posted
Jan 29, 2009

2005 – 2008

United States locations

U.S. sites
27
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
Central Hematology Oncology Medical Group Inc Alhambra California 91801
Comprehensive Blood and Cancer Center Bakersfield California 93309
Providence Saint Joseph's Medical Center (PSJMC) Burbank California 91505
Pacific Oncology & Hematology Associates Encinitas California 92024
Virginia K. Crosson Cancer Center Fullerton California 92835
Pacific Shores Medical Group Long Beach California 90813-3244
UCLA Clinical Research Unit Los Angeles California 90095
North Valley Hematology/Oncology Medical Group, The Thomas and Dorothy Leavey Cancer Center Northridge California 91328
Ventura County Hematology-Oncology Specialists Oxnard California 93030
Cancer Care Associates Medical Group, Inc Redondo Beach California 90277
Sansum Santa Barbara Medical Foundation Clinic Santa Barbara California 93105
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105
Central Coast Medical Oncology Corporation Santa Maria California 93454
Stanford University Medical Center-Cancer Center Stanford California 94305
University of Miami School of Medicine Miami Florida 33136
Peachtree Hematology and Oncology Atlanta Georgia 30309
Oncology Hematology Associates of Central Illinois,PC Peoria Illinois 61615
Ochsner Cancer Institute New Orleans Louisiana 70121
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-1000
Park Nicollet Institute Saint Louis Park Minnesota 55416
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109
Columbia University Medical Center New York New York 10032
Staten Island Urological Research Staten Island New York 10304
Biomedical Research Alliance of New York (BRANY) The Bronx New York 10461
Cleveland Clinic Foundation Cleveland Ohio 44195
University of Virginia Health System Charlottesville Virginia 22908
Marshfield Clinic Foundation Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00111618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2009 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00111618 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →